000			03500nam a2200325 i 4500
999			_c402212 _d402212
001			402212
003			ES-MaUEC
005			20240607103353.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			230208s2023 sz | fo |||| 0|eng d
020			_a9783031177590
024	7		_a10.1007/978-3-031-17759-0 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC632 .A5 _b2023 EB
245	0	0	_aAmyloidosis and Fabry Disease : _bA Clinical Guide _cedited by Diane Xavier de Ávila, Humberto Villacorta Junior
250			_a1st ed. 2023
264		1	_aCham _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aDescription and Purposes: An Overview -- Neurological Manifestations -- Dysautonomy -- Cardiology Manifestations -- Syncope, Arrhythmia and Cardiac Devices -- Urological and Kidney manifestations -- Ophthalmological and Dermatological Manifestations -- Gastrointestinal Symptoms -- Hematological Associations -- Orthopedic Care -- Association of Neoplasms -- Diagnostic tools -- Genetics and Epigenetics -- Treatment -- Clinical Course: An Overview -- Neurological Manifestations -- Cardiology Manifestations -- Kidney manifestations -- Ophthalmological and Dermatological Manifestations -- Gastrointestinal Symptoms -- Diagnostic tools -- Genetics -- Treatment -- Pathology and Differential Diagnosis -- Clinical Research -- The Role of Nursing in Chronic Patient's Care -- Chronic Pain and Quality of Life.
520			_aThis book presents a multispecialty and multidisciplinary approach on Amyloidosis and Fabry disease. These two "rare" diseases are underdiagnosed and have systemic peculiarities that should be emphasized for diagnosis. In both cases, early diagnosis is important for initiating treatment sooner, achieving better prognosis, and improving patients' quality of life. The history of these patients, in general, involves a long journey among health professionals to obtain a diagnosis. Even after a patient is diagnosed, there are still difficulties in understanding these complex diseases, managing complications, and defining specific treatment. Therefore, this work will be a valuable resource for many healthcare professionals, including physicians of various specialties, nurses, physiotherapists, and medical students. It will also be of interest to patients who would like to understand Amyloidosis and Fabry disease. The content will give healthcare professionals a clinical perspective and provide insights on proper care. Readers will be able to recognize the symptoms related to each disease and will be guided during diagnosis and treatment. Chapters include an overview on clinical course, and will address neurological, ophthalmological, dermatological, gastrointestinal, hematological and cardiology manifestations, orthopedic care, mutations, expressiveness according to epigenetics and multidisciplinary treatment. Chapter authors from around the world have contributed sharing their experience in managing these diseases.
988			_aSpringer_Medicine_2023
650		7	_2embne _9145189 _aAmiloidosis
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-17759-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b06/2024 _dz _eb _zSI